Leandro L Santos

4PUBLICATIONS
14CO-AUTHORS
Toxicology (incl. clinical toxicology)Gene and molecular therapyRadiation therapyPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Oct 02, 2026
Comparative Pharmacologic Characterization of Povorcitinib (INCB054707) as a Highly Selective Oral JAK1 Inhibitor.

|Aug 08, 2026
Prevalence and Clinical Characteristics of Vitiligo-Associated Hearing Loss Among Patients in a Phase 2 Clinical Trial of Povorcitinib.

|Jul 13, 2026
Post Hoc Subgroup and Body Region Analyses of VASI Outcomes Among Patients with Vitiligo in a Phase 2 Povorcitinib Trial.

|Apr 28, 2023
Modulation of Disease-Associated Pathways in Hidradenitis Suppurativa by the Janus Kinase 1 Inhibitor Povorcitinib: Transcriptomic and Proteomic Analyses of Two Phase 2 Studies.

Huiqing Liu, Leandro L Santos, Susan H Smith

Pageof 1

Frequent Collaborators

2 joint publications

Zhenyi Xue

1 joint publications

Thierry Passeron

1 joint publications

Amit G Pandya

1 joint publications

Khaled Ezzedine